newsfilter
← Latest News
ACCESS Newswire·

NovAccess Global Readies for Development of Novel Immunotherapies for Brain Tumor Patients with pre-IND meeting scheduled with the FDA and Files Form 10-K for Fiscal 2020 and Form 10-Q for FQ1/FQ2, 2021

CLEVELAND, OH / ACCESSWIRE / June 8, 2021 / NovAccess Global, Inc. (OTC:XSNX) (the 'Company' or 'NovAccess'), a cancer therapeutics company with operations in biotechnology, is pleased to announce that it has filed the Form 10-K annual filing for the fis